Upgrade to SI Premium - Free Trial

Celgene (CELG) PT Lowered to $140 at Canaccord Genuity

October 27, 2017 11:05 AM
Canaccord Genuity lowered its price target on Celgene (NASDAQ: CELG) to $140.00 (from $154.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles